Resources

Resource types
  • Resource types

  • Resource types

John McShane recently joined biomodal as our Director of Business Development for Eastern North America and Canada.
Chad Geringer recently joined biomodal and focuses on business development in North America.
Dr Aziz Mustafa recently joined biomodal as our Director of Sales and Business Development for Europe. We caught up with Aziz to learn more about him, his background, and what excites him about the field of epigenetics.
The Aparicio lab at the British Columbia Cancer Research Centre (BCCRC) utilises 5-letter sequencing technology, duet multiomics solution +modC, to investigate ‘epigenetic rewiring’ in breast cancer cells.
Review performance of duet multiomics solution +modC for the detection of genetic and epigenetic sequence data at base resolution when using formalin damaged DNA. Samples include formalin-compromised DNA standards (fcDNA) as well as DNA extracted from formalin-fixed and paraffin-embedded (FFPE) samples of two colorectal cancer (CRC) patients.
Representatives from our R&D team presented 3 posters at the Advances in Genome Biology & Technology General Meeting in Hollywood, Florida.
We are extremely proud to announce that our paper ‘Simultaneous sequencing of genetic and epigenetic bases in DNA’ has been published by the journal Nature Biotechnology.
Cambridge Epigenetix is now biomodal